Nymox Pharmaceutical Corp (NASDAQ:NYMX)

CAPS Rating: 1 out of 5

A biopharmaceutical company with three proprietary products on the market and a R&D of drug & diagnostic products in development for the treatment of enlarged prostate, Alzheimer's disease contamination of food and drink products and bacterial infections.

Caps

How do you think NYMX will perform against the market?

Add Stock to CAPS Watchlist

All Players

65 Outperform
61 Underperform
 

All-Star Players

10 Outperform
32 Underperform
 

Wall Street

0 Outperform
1 Underperform
 

Top NYMX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mshakin1 (< 20)
Submitted May 27, 2010

The NYMOX drug for BPH, NX1207, is head and shoulders above all the existing drugs for this ailment, which affects tens of millions of middle age and elderly men. Not only is NX1207 so much more effective than Flomax and Avodart is decreasing BPH,… More

zzlangerhans (99.80)
Submitted March 25, 2015

As far as biopharma stocks go, they don't get much worse than the Canadian scam Nymox. Despite the predictable failure of the phase III trials of NX03-0040 for BPH which dropped the stock as low as 0.36, Nymox has been caught up in the wave of… More

NYMX VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about NYMX.

Recs

0
Member Avatar superstar2 (99.36) Submitted: 9/13/2016 12:15:20 PM : Outperform Start Price: $3.69 NYMX Score: -19.04

Impressive stage3 trial results on lead drug Fexapotide.

Recs

0
Member Avatar RES7 (99.08) Submitted: 8/10/2016 1:00:18 PM : Underperform Start Price: $1.85 NYMX Score: -77.21

pearson

Recs

0
Member Avatar PrototypeZ (32.35) Submitted: 1/6/2016 11:33:09 AM : Underperform Start Price: $0.64 NYMX Score: -427.67

Bio lemming pick zz

Leaderboard

Find the members with the highest scoring picks in NYMX.

Score Leader

BravoBevo

BravoBevo (99.96) Score: +397.02

God never does anything to cover a deficiency because He has none. Instead, everything that God does is to display His sufficiency, which is infinite. The chief end of God (and also should be of man) is to glorify God and to enjoy God forever.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
pro64grammer 28.95 11/3/2014 Outperform 5Y $0.93 +275.67% +19.98% +255.69 0 Comment
BetapegAnalytics < 20 8/18/2009 Underperform 5Y $4.51 -22.62% +147.51% +170.12 0 Comment
BicaChica 79.98 10/12/2009 Underperform 5Y $4.66 -25.11% +125.23% +150.34 0 Comment
Okcfirefighter < 20 12/17/2010 Underperform 5Y $7.20 -51.53% +95.20% +146.73 0 Comment
RUMBLINstrflame < 20 12/2/2009 Underperform 5Y $4.52 -22.79% +118.11% +140.90 0 Comment
boardwalken65 31.11 7/5/2011 Underperform 3M $8.24 -57.65% +81.42% +139.07 0 Comment
longtermgrowth09 < 20 12/17/2009 Underperform 5Y $4.27 -18.27% +119.21% +137.48 0 Comment
roth450 28.39 7/23/2010 Underperform NS $3.80 -8.16% +122.18% +130.34 0 Comment
Bigsef77 70.11 4/24/2015 1/11/2016 Outperform 3Y $1.47 +137.41% +14.78% +122.63 0 Comment
Fastball07 65.82 11/20/2007 Underperform 3M $6.40 -45.47% +76.56% +122.03 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackBioLogicEqu < 20 2/15/2011 Underperform NS $6.49 -46.22% +82.46% +128.69 0 Comment